• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW 0.00% 2.4¢

ACTINOGEN MEDICAL LIMITED - News & Media

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight arrow Created with Sketch.

Actinogen reveals XanaCIDD phase 2a trials
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $65.08M
Open High Low Value Volume
2.4¢ 2.5¢ 2.1¢ $526.7K 22.84M

Buyers (Bids)

No. Vol. Price($)
5 431842 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 499979 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
2.4¢
  Change
0.000 ( 1.69 %)
Open High Low Volume
2.4¢ 2.5¢ 2.1¢ 9368279
Last updated 15.59pm 23/08/2024 ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.